Product Information
ROSUVASTATIN CALCIUM 40 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0686 per EA under NDC 82009002010. Its NADAC has been published 159 times since Aug 9, 2023.
FDA first approved this application on Nov 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009002010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208898FDA Approved
11/22/2017
TE Code
AB
On Market Since
3/9/2022
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has been published 159 times since Aug 9, 2023, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0686 per EA |
|---|---|
| All-time high | $0.1218 (Sep 13, 2023) |
| All-time low | $0.0591 (Apr 22, 2026) |
| 52-week high | $0.0754 |
| 52-week low | $0.0591 |
| Median price | $0.0866 |
| Average price | $0.0870 |
| Largest weekly change | +25.6% (Aug 21, 2024) |
| Weeks tracked | 159 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 40 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0686 per EA (NDC 82009002010), effective Aug 19, 2026.
How has the price of ROSUVASTATIN CALCIUM 40 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has declined 39.7%. It has been tracked across 159 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 40 MG TAB?
Since Aug 9, 2023, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has ranged from a low of $0.0591 (Apr 22, 2026) to a high of $0.1218 (Sep 13, 2023), with a median of $0.0866 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 40 MG TAB?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 40 MG TAB, is $0.0624 per EA — about 9% below ROSUVASTATIN CALCIUM 40 MG TAB.
Who manufactures ROSUVASTATIN CALCIUM 40 MG TAB?
ROSUVASTATIN CALCIUM 40 MG TAB (NDC 82009002010) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.